Embla Medical hf.
OSSFF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $68,298 | $58,706 | $42,621 | $64,189 |
| Dep. & Amort. | $55,989 | $50,191 | $49,490 | $51,685 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $0 | $0 |
| Change in WC | -$8,732 | -$13,393 | -$22,300 | -$20,919 |
| Other Non-Cash | $544 | -$668 | -$8,885 | $5,882 |
| Operating Cash Flow | $116,100 | $94,836 | $60,925 | $100,836 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$39,238 | -$42,507 | -$26,008 | -$26,769 |
| Net Acquisitions | -$79,743 | -$11,968 | -$41,890 | -$34,043 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $4,530 | -$2,982 | $1,469 | $1,185 |
| Investing Cash Flow | -$114,451 | -$57,457 | -$66,429 | -$59,628 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $39,800 | -$14,857 | $35,714 | -$29,787 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | -$9,966 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$24,386 | -$26,324 | -$21,950 | -$21,441 |
| Financing Cash Flow | $15,413 | -$41,181 | $3,799 | -$51,228 |
| Forex Effect | -$3,508 | -$126 | -$6,860 | -$7,214 |
| Net Chg. in Cash | $13,554 | -$3,929 | -$8,566 | -$17,235 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $72,653 | $76,582 | $85,148 | $102,382 |
| End Cash | $86,207 | $72,653 | $76,582 | $85,148 |
| Free Cash Flow | $89,059 | $65,444 | $44,336 | $83,825 |